- Home
- ASND vs MGM Comparison
ASND vs MGM Comparison
Compare ASND & MGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- MGM
- Stock Information
- Founded
- ASND 2006
- MGM 1986
- Country
- ASND Denmark
- MGM United States
- Employees
- ASND N/A
- MGM N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- MGM Hotels/Resorts
- Sector
- ASND Health Care
- MGM Consumer Discretionary
- Exchange
- ASND Nasdaq
- MGM Nasdaq
- Market Cap
- ASND 10.6B
- MGM 10.8B
- IPO Year
- ASND 2015
- MGM N/A
- Fundamental
- Price
- ASND $205.91
- MGM $36.69
- Analyst Decision
- ASND Strong Buy
- MGM Buy
- Analyst Count
- ASND 16
- MGM 16
- Target Price
- ASND $240.75
- MGM $48.29
- AVG Volume (30 Days)
- ASND 510.4K
- MGM 3.9M
- Earning Date
- ASND 08-07-2025
- MGM 10-29-2025
- Dividend Yield
- ASND N/A
- MGM N/A
- EPS Growth
- ASND N/A
- MGM N/A
- EPS
- ASND N/A
- MGM 1.84
- Revenue
- ASND $576,332,355.00
- MGM $17,211,652,000.00
- Revenue This Year
- ASND $101.37
- MGM $1.46
- Revenue Next Year
- ASND $76.17
- MGM $2.00
- P/E Ratio
- ASND N/A
- MGM $19.94
- Revenue Growth
- ASND 54.50
- MGM 0.76
- 52 Week Low
- ASND $111.09
- MGM $25.30
- 52 Week High
- ASND $207.00
- MGM $42.54
- Technical
- Relative Strength Index (RSI)
- ASND 68.12
- MGM 46.16
- Support Level
- ASND $195.00
- MGM $36.00
- Resistance Level
- ASND $203.59
- MGM $39.14
- Average True Range (ATR)
- ASND 6.41
- MGM 0.93
- MACD
- ASND 0.27
- MGM -0.07
- Stochastic Oscillator
- ASND 93.94
- MGM 19.68
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About MGM MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 37,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 59% of total EBITDAR in 2024. MGM also owns US regional assets, which represented a low 20s share of 2024 EBITDAR (MGM's Macao EBITDAR was 21% of the total in 2024). MGM's US sports and i-gaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. We estimate MGM will open a resort in Japan in 2030.